EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

Guideline-based lipid-lowering therapy in acute coronary syndromes: A simulation of population-level impact on cardiovascular events and LDL-C goal achievement

Dylan L Steen, Kausik K Ray, Irfan Khan, Alberico L Catapano, Deepak L Bhatt, Alexandra Koumas, Kaja Pol, Robert P Giugliano

Journal of Clinical Lipidology · 2026-05 · 20 (5) · 887-897

DOI: 10.1016/j.jacl.2026.03.007 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of Clinical Lipidology, 2026-05. Verfasst von Dylan L Steen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Health and Disease, Department of Medicine, University of Cincinnati, Cincinnati, OH, USA (Steen). Electronic address: dyl…. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Cholesterol, LDL, Hypolipidemic Agents. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sanofi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Coronary SyndromeCholesterol, LDLHypolipidemic AgentsHumansMaleFemaleAgedMiddle AgedMonte Carlo MethodEzetimibeHydroxymethylglutaryl-CoA Reductase InhibitorsAntibodies, Monoclonal, HumanizedAnticholesteremic Agents

Stichwörter der Autor:innen

Acute coronary syndromesCardiovascular riskLDL-C goalsLipid-lowering therapySimulation modeling

Substanzen

Cholesterol, LDLEzetimibeHydroxymethylglutaryl-CoA Reductase InhibitorsAntibodies, Monoclonal, HumanizedHypolipidemic AgentsAnticholesteremic Agentsalirocumab

Autor:innen und Institutionen

  • Division of Cardiovascular Health and Disease, Department of Medicine, University of Cincinnati, Cincinnati, OH, USA (Steen). Electronic address: dylan.steen@uc.edu.
  • Imperial Clinical Trials Unit, Imperial College London, London, UK (Ray).
  • Sanofi, Morristown, NJ, USA (Khan).
  • IRCCS MultiMedica, Milan, Italy (Catapano); Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy (Catapano).
  • Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, NY, USA (Bhatt).
  • Axtria, Berkley Heights, NJ, USA (Koumas).

Förderung

  • Sanofi

Zitieren

APA

Steen, D. L., Ray, K. K., Khan, I., Catapano, A. L., Bhatt, D. L., Koumas, A., Pol, K., & Giugliano, R. P. (2026). Guideline-based lipid-lowering therapy in acute coronary syndromes: A simulation of population-level impact on cardiovascular events and LDL-C goal achievement. Journal of Clinical Lipidology, 20(5), 887-897. https://doi.org/10.1016/j.jacl.2026.03.007

Vancouver

Steen DL, Ray KK, Khan I, Catapano AL, Bhatt DL, Koumas A, et al. Guideline-based lipid-lowering therapy in acute coronary syndromes: A simulation of population-level impact on cardiovascular events and LDL-C goal achievement. Journal of Clinical Lipidology. 2026;20(5):887-897. doi:10.1016/j.jacl.2026.03.007

BibTeX
@article{Steen2026,
  author = {Steen, Dylan L and Ray, Kausik K and Khan, Irfan and Catapano, Alberico L and Bhatt, Deepak L and Koumas, Alexandra and Pol, Kaja and Giugliano, Robert P},
  title = {Guideline-based lipid-lowering therapy in acute coronary syndromes: A simulation of population-level impact on cardiovascular events and LDL-C goal achievement},
  journal = {Journal of Clinical Lipidology},
  year = {2026},
  volume = {20},
  number = {5},
  pages = {887--897},
  doi = {10.1016/j.jacl.2026.03.007}
}
Kostenlos starten →